Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	219,542	237,046	204,567	166,141	96,135	69,112
Short-Term Investments	80	60	4,479	-	20	60
Cash & Short-Term Investments	219,622	237,106	209,046	166,141	96,155	69,172
Cash Growth	57.82%	13.42%	25.82%	72.78%	39.01%	8.04%
Receivables	130,994	145,936	135,022	136,066	114,396	99,788
Inventory	55,754	57,451	74,864	48,629	44,814	41,817
Prepaid Expenses	-	15,426	20,670	14,699	10,465	10,952
Other Current Assets	30,181	12,389	15,502	48,061	79,271	59,537
Total Current Assets	436,551	468,308	455,104	413,596	345,101	281,266
Property, Plant & Equipment	100,898	101,419	105,721	104,752	108,420	112,131
Long-Term Investments	102,558	104,793	100,975	297,170	324,178	255,997
Goodwill	23,009	22,654	21,186	-	-	-
Other Intangible Assets	354,955	353,581	330,041	57,288	69,134	64,734
Long-Term Deferred Tax Assets	55,001	55,759	51,020	40,863	35,604	25,074
Other Long-Term Assets	11,441	1	-1	-1	-	1
Total Assets	1,084,413	1,106,515	1,064,046	913,668	882,437	739,203

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	49,376	62,951	89,329	60,691	66,794	49,689
Accrued Expenses	-	23,787	19,350	13,493	11,726	10,824
Short-Term Debt	39,420	5,389	-	-	-	-
Current Portion of Long-Term Debt	-	30,000	30,000	-	-	-
Current Portion of Leases	2,890	3,078	3,178	2,310	2,490	2,301
Current Income Taxes Payable	9,044	35,890	4,319	24,518	40,896	2,284
Other Current Liabilities	32,231	2,550	2,120	2,612	1,023	828
Total Current Liabilities	132,961	163,645	148,296	103,624	122,929	65,926
Long-Term Debt	67,500	75,000	105,000	-	-	-
Long-Term Leases	7,290	7,468	8,500	6,552	6,678	6,501
Pension & Post-Retirement Benefits	2,505	2,234	2,640	3,294	3,350	3,322
Long-Term Deferred Tax Liabilities	847	909	10,817	1,013	983	1,009
Other Long-Term Liabilities	570	615	591	580	684	771
Total Liabilities	211,673	249,871	275,844	115,063	134,624	77,529

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	17,358	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	-	17,378	17,458	17,458	17,080	17,241
Retained Earnings	835,356	830,086	790,908	768,183	709,890	644,754
Treasury Stock	-62,770	-62,770	-63,063	-63,233	-54,161	-74,683
Comprehensive Income & Other	76,887	48,675	19,790	53,195	51,702	51,236
Total Common Equity	866,831	850,727	782,451	792,961	741,869	655,906
Minority Interest	5,909	5,917	5,751	5,644	5,944	5,768
Shareholders' Equity	872,740	856,644	788,202	798,605	747,813	661,674
Total Liabilities & Equity	1,084,413	1,106,515	1,064,046	913,668	882,437	739,203

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	117,100	120,935	146,678	8,862	9,168	8,802
Net Cash (Debt)	102,522	116,171	62,368	157,279	86,987	60,370
Net Cash Growth	9710.72%	86.27%	-60.35%	80.81%	44.09%	9.82%
Net Cash Per Share	218.17	247.19	132.76	327.64	178.12	121.58
Filing Date Shares Outstanding	469.91	469.91	469.77	469.65	488.33	488.31
Total Common Shares Outstanding	469.91	469.91	469.77	469.65	488.33	488.24
Working Capital	303,590	304,663	306,808	309,972	222,172	215,340
Book Value Per Share	1844.69	1810.41	1665.59	1688.42	1519.18	1343.40
Tangible Book Value	488,867	474,492	431,224	735,673	672,735	591,172
Tangible Book Value Per Share	1040.35	1009.76	917.94	1566.44	1377.61	1210.81

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error